Frequency of secondary T-cell lymphoma in chimeric antigen receptor Tcell naïve B-cell lymphoid-lineage cancers is higher than that reported on chimeric antigen receptor T-cell therapy
Authors
Christian Brieghel (ORCID: https://orcid.org/0000-0002-1816-8106)
Peter de Nully Brown (ORCID: https://orcid.org/0000-0002-6522-4086)
Frequency of secondary T-cell lymphoma in chimeric antigen receptor Tcell naïve B-cell lymphoid-lineage cancers is higher than that reported on chimeric antigen receptor T-cell therapy
Christian Brieghel, Peter de Nully Brown, Carsten Utoft Niemann, Søren Lykke Petersen
Local Database Links
1 links
Journal
Haematologica
Topics
CAR-T cell therapy research
article
Frequency of secondary T-cell lymphoma in chimeric antigen receptor Tcell naïve B-cell lymphoid-lineage cancers is higher than that reported on chimeric antigen receptor T-cell therapy
Christian Brieghel, Peter de Nully Brown, Carsten Utoft Niemann, Søren Lykke Petersen
article en
Abstract
No abstract available for this paper.
Publication Tag
HaematologicaVol. 110(3)
Institutions
Copenhagen University Hospital (DK), Rigshospitalet (DK)
Funders
Eli Lilly and Company, AstraZeneca, Gilead Sciences, CSL Behring, BeiGene, European Commission, Novo Nordisk, Science and Engineering Research Board